Merck Sharp & Dohme Corp.;Board of Regents of the University of Texas System
发明人:
Tong-Ming Fu,Dai Wang,Zhiqiang An
申请号：
US14897374
公开号：
US09868777B2
申请日:
2014.06.09
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention is directed to antigen binding proteins including, but not limited to, monoclonal antibodies and antigen binding fragments thereof, that specifically bind to and preferably neutralize human cytomegalovirus (CMV). Also encompassed by the invention are antigen binding proteins that have been humanized. The antigen binding proteins of the invention are useful as a therapeutic agent for treating and/or preventing CMV infections in a patient in need thereof.
